Your browser doesn't support javascript.
loading
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.
Vesikari, Timo; Langley, Joanne M; Segall, Nathan; Ward, Brian J; Cooper, Curtis; Poliquin, Guillaume; Smith, Bruce; Gantt, Soren; McElhaney, Janet E; Dionne, Marc; van Damme, Pierre; Leroux-Roels, Isabel; Leroux-Roels, Geert; Machluf, Nathalie; Spaans, Johanna N; Yassin-Rajkumar, Bebi; Anderson, David E; Popovic, Vlad; Diaz-Mitoma, Francisco.
Affiliation
  • Vesikari T; Nordic Research Network, Tampere, Finland.
  • Langley JM; Departments of Pediatrics and Community Health and Epidemiology, Canadian Center for Vaccinology, Halifax, NS, Canada.
  • Segall N; Clinical Research Atlanta, Stockbridge, GA, USA.
  • Ward BJ; McGill University Health Centre-Vaccine Study Centre, Montreal, QC, Canada.
  • Cooper C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Poliquin G; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
  • Smith B; Department of Mathematics and Statistics, Dalhousie University, Halifax, NS, Canada.
  • Gantt S; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.
  • McElhaney JE; Health Sciences North Research Institute, Sudbury, ON, Canada.
  • Dionne M; University of Laval, Quebec City, QC, Canada.
  • van Damme P; University of Antwerp-Center for the Evaluation of Vaccination, Universiteitsplein, Wilrijk, Belgium.
  • Leroux-Roels I; Center for Vaccinology, Ghent University, Gent, Belgium.
  • Leroux-Roels G; Center for Vaccinology, Ghent University, Gent, Belgium.
  • Machluf N; VBI Vaccines, Cambridge, MA, USA.
  • Spaans JN; VBI Vaccines, Cambridge, MA, USA.
  • Yassin-Rajkumar B; VBI Vaccines, Cambridge, MA, USA.
  • Anderson DE; VBI Vaccines, Cambridge, MA, USA.
  • Popovic V; VBI Vaccines, Cambridge, MA, USA.
  • Diaz-Mitoma F; VBI Vaccines, Cambridge, MA, USA. Electronic address: fdiazmitoma@vbivaccines.com.
Lancet Infect Dis ; 21(9): 1271-1281, 2021 09.
Article in En | MEDLINE | ID: mdl-33989539
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B Vaccines / Immunogenicity, Vaccine / Hepatitis B / Hepatitis B Antibodies / Antigens, Viral Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Asia / Europa Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Finlandia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B Vaccines / Immunogenicity, Vaccine / Hepatitis B / Hepatitis B Antibodies / Antigens, Viral Type of study: Clinical_trials / Guideline Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Asia / Europa Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Finlandia